Life_science_landing_header_1920x460
990 (2)-2

Third-Party Risk Management for Life Sciences

From risk to resilience

Ethixbase360 smart automation with expert-led due diligence and responsive support gives our clients a clear, connected view of global third-party risk to withstand regulatory scrutiny and address complex global value chains with speed, flexibility and responsiveness.

Trusted by Leading Brands in Life Sciences

Sonova
ASCENSIA Diabetes Care
Shockwave Medical
Kelix bio
Recipharm
Sigma Healthcare
Lupin
Medicines360

Insights from Ethixbase360:

From Risk to Resilience

James Swenson, Ethixbase360 Managing Director discusses the need for a clear, connected view of global third-party risk to withstand regulatory scrutiny and address complex global value chains in this high trust industry.

2026 Outlook: Navigating Third-Party Risk in the Pharmaceutical and Life Sciences Sector

Since the release of our 2025 Outlook, the regulatory and enforcement landscape has continued to shift. Pharmaceutical and life sciences companies face sustained regulatory scrutiny, expanding ESG obligations, and intensifying geopolitical pressure on global supply chains. The 2026 edition reflects these developments, examining how regulatory expectations are rising and how enforcement activity continues to evolve across jurisdictions.

eBook-Life Sciences Outlook 2026
Untitled design (10)

Take Control of Third-Party Risk

 Award-winning software that helps you reduce risk, improve visibility, and stay ahead of evolving regulations.
2026 G2 Best Software Award Winner. 

Case Studies

Leading Global Eyecare Company

CASE STUDY

Leading Global Eyecare Company

In a high-risk regulatory environment, a leading global eyecare company needed a powerful solution to manage third-party risk, ensure compliance, and support growth.

Sonova case study

CASE STUDY 

Sonova

From manual to automated, Ethixbase360 accelerated and simplified the entire third-party compliance and due diligence process for Sonova.

Terumo Aortic case study cover

CASE STUDY

Terumo Aortic

Terumo Aortic is a global medical devices company dedicated to developing innovative solutions for aortic and peripheral vascular disease.

Improve clarity with
a connected view of
third-party risk

 

Blogs

Blog Post IMG PREVIEW (3)-3

BLOG

The Importance of TPRM in Facilitating Ethical Transactions with HCPs

In the Life Sciences industry, maintaining ethical and transparent relationships with healthcare professionals (HCPs) is fundamental to trust, patient safety, and business [...]

Blog-Post-IMG-PREVIEW-1

BLOG

The Role of Enhanced Due Diligence in Pharma M&A

From undisclosed state-linked ownership and historical sanctions breaches to unethical clinical practices or human-rights issues deep within supply chains, these hidden exposures can [...]

How Ethixbase360 helps Life Sciences organizations

Ensure you and your third parties reach the highest global regulatory standards +

Refine your third-party risk-based approach through automation backed by human insight +

Elevate visibility of third-party risk to protect against reputational damage +

Built for speed, transparency,
and configurability, supported by
expert-led due diligence

Read Our G2 Reviews

Let's Talk

Let's Talk

Ready to take the risk out of the equation?